Company news
Theratechnologies Inc. news in 2005
Theratechnologies Inc.'s news releases, calls and decks from 2005, newest first.
Theratechnologies' common shares now eligible for inclusion in the SMB Growth Stock Plan
November 22, 2005
Theratechnologies: TH9507 Phase 3 study advancing rapidly
October 13, 2005
European pharmaceutical executive joins the Board of Theratechnologies
August 9, 2005
Theratechnologies: Financial results for the second quarter and recent operating highlights
July 13, 2005
Theratechnologies launches Phase III clinical trial for TH9507 (ThGRF) treating HIV-associated lipodystrophy
July 5, 2005
Theratechnologies closes the sale of its investment in Celmed BioSciences
June 20, 2005
Theratechnologies: four scientific posters at the Endocrine Society Annual Meeting
June 6, 2005
Theratechnologies reports on a positive meeting with Health Canada for its ThGRF Phase III program
May 4, 2005
PRESS CONFERENCE - Theratechnologies Inc. - Invitation to Media
April 13, 2005
Theratechnologies: Financial results for the first quarter of 2005 and recent operating highlights
April 13, 2005
PRESS CONFERENCE - Theratechnologies Inc. - Invitation to Media
April 11, 2005